Notable Approvals | Drugs

Synopsis

Notable Approvals | Drugs Title Date Posted Brand Name Active Ingredient FDA Approves First Once-Weekly Insulin for Type 2 Diabetes Mellitus in Pediatric Patients 10/23/2026 Awiqli insulin icodec-abae FDA Approves Drug to Treat Lesions Caused by Herpes Simplex Virus 10/9/2026 Hovilpri pritelivir FDA approves first drug to improve functional capacity and symptoms in children with rare inherited heart condition 9/30/2026 Camzyos mavacamten FDA Approves Third Treatment for Fibro

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.